University of Zurich-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013600
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Zurich (UZH) is an educational and research university that provides bachelor, master and doctorate programs. The university offers courses in the areas of theology, law, business, economics and informatics, medicine, veterinary medicine, arts and social sciences. Its research activities include national, academic, clinical and faculty priorities. UZH provides libraries which include main library university of Zurich and Zurich central library. The university also offers counseling centers for students, study and course selection. It works in cooperation with national and international committees and organizations including League of European Research Universities, European University Association, and International Association of Universities, among others. UZH is headquartered in Zurich, Switzerland.

University of Zurich – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Zurich, Medical Devices Deals, 2011 to YTD 2017 9
University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Zurich, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 11
Licensing Agreements 13
The Geneva Biotech Enters into Licensing Agreement with University of Zurich 13
Viventia Bio Enters into Licensing Agreement with University of Zurich 14
Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 15
Neuway Pharma Enters into Licensing Agreement with University of Zurich 16
Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 17
University of Zurich – Key Competitors 18
University of Zurich – Key Employees 19
University of Zurich – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Recent Developments 21
Government and Public Interest 21
May 30, 2017: Better treatment for kidney cancer thanks to new mouse model 21
Apr 04, 2017: Common antibiotic may help to prevent or treat PTSD 22
Jun 03, 2016: Promising treatment prospects for invasive breast cancer 23
Apr 18, 2016: Psilocybin reduces psychological pain after social exclusion 24
Apr 14, 2016: Wayne State receives $2.5 million NIH grant to shape next generation of antibiotics 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
University of Zurich, Pharmaceuticals & Healthcare, Key Facts 2
University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Zurich, Deals By Therapy Area, 2011 to YTD 2017 8
University of Zurich, Medical Devices Deals, 2011 to YTD 2017 9
University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 11
The Geneva Biotech Enters into Licensing Agreement with University of Zurich 13
Viventia Bio Enters into Licensing Agreement with University of Zurich 14
Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 15
Neuway Pharma Enters into Licensing Agreement with University of Zurich 16
Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 17
University of Zurich, Key Competitors 18
University of Zurich, Key Employees 19
University of Zurich, Subsidiaries 20
University of Zurich, Joint Venture 20

★海外企業調査レポート[University of Zurich-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SunPower Corporation (SPWR)-エネルギー分野:企業M&A・提携分析
    Summary SunPower Corporation (SunPower), a subsidiary of Total Energies Nouvelles Activites USA, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procure …
  • BioDiem Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal dis …
  • Ernst & Young Global Ltd:戦略・SWOT・企業財務分析
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Asiana Airlines Inc.:企業の戦略・SWOT・財務情報
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Saudi Airlines Catering:企業の戦略・SWOT・財務分析
    Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report Summary Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Bank of Yokohama Ltd:企業の戦略・SWOT・財務分析
    The Bank of Yokohama Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Yokohama Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sonic Healthcare Ltd (SHL)-医療機器分野:企業M&A・提携分析
    Summary Sonic Healthcare Ltd (Sonic Healthcare) Sonic Healthcare is a medical diagnostics company that provides laboratory and diagnostic imaging services. The company provides laboratory medicine, pathology, radiology, diagnostic imaging and primary care medical services. It operates Australia's la …
  • ALS Ltd (ALQ):企業の財務・戦略的SWOT分析
    ALS Ltd (ALQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • REV Group, Inc. (REVG):企業の財務・戦略的SWOT分析
    REV Group, Inc. (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • The Lubrizol Corporation-製薬・医療分野:企業M&A・提携分析
    Summary The Lubrizol Corporation (Lubrizol), a subsidiary of Berkshire Hathaway Inc., is a specialty chemical company that produces and supplies technologies to the global transportation, industrial, and consumer markets. Its products and services include engine additives, driveline additives, indus …
  • amcure GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Amcure GmbH (Amcure) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of cancer. The company develops peptide-based compounds for the treatment of metastatic forms of cancer. Its lead candidate, AMC303 is used for the treatment of metastatic epithelia …
  • Northwest Territories Power Corp:企業の戦略的SWOT分析
    Northwest Territories Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Custodian & Allied Plc:企業の戦略・SWOT・財務分析
    Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report Summary Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MitoGenetics LLC-製薬・医療分野:企業M&A・提携分析
    Summary MitoGenetics LLC (MitoGenetics) is a biomedical research and development company which produces proprietary compounds and intellectual property for the treatment of human, animal and plant diseases caused due to mitochondrial dysfunction. The company offers technology to regulate cellular mi …
  • ABX Air, Inc.:企業の戦略的SWOT分析
    ABX Air, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • HearMeOut Ltd (HMO):企業の財務・戦略的SWOT分析
    HearMeOut Ltd (HMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Marina Biotech Inc (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Marina Biotech Inc (Marina) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆